|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 47/61 | |
| A61K 47/56 | |||
| A61K 47/54 | |||
| A61K 31/7125 | |||
| A61P 1/16 |
| (11) | Patento numeris | 3439703 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 17715730.2 |
| Europos patento paraiškos padavimo data | 2017-04-05 | |
| (97) | Europos patento paraiškos paskelbimo data | 2019-02-13 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2020-04-29 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/EP2017/058112 |
| Data | 2017-04-05 |
| (87) | Numeris | WO 2017/174657 |
| Data | 2017-10-12 |
| (30) | Numeris | Data | Šalis |
| 16163939 | 2016-04-05 | EP |
| (72) |
FRAUENDORF, Christian, DE
CAMERON, Mark, DE
|
| (73) |
Silence Therapeutics GmbH,
Robert-Rössle-Strasse 10, 13125 Berlin,
DE
|
| (54) | NUCLEIC ACID LINKED TO A TRIVALENT GLYCOCONJUGATE |
| NUCLEIC ACID LINKED TO A TRIVALENT GLYCOCONJUGATE |